H1B Report
Side-by-side comparison

PharmaACE LLC vs Microsoft Corporation

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
PharmaACE LLC
NJRank #FEIN 46-2529158
Entity B
Microsoft Corporation
WARank #6FEIN 91-1144442

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricPharmaACE LLCMicrosoft Corporation
Total filings12470,316
Certified %95.16%94.15%
Denied %3.23%0.12%
Withdrawn %1.61%0.71%
Cert-withdrawn %0.00%5.02%
Rank#6
Active yearsFY2011–FY2026FY2010–FY2026
Worksite stateNJWA

Outcomes — PharmaACE LLC

DOL case-status mix.

Outcome breakdown: Certified 95.2%, Withdrawn 1.6%, Denied 3.2%
Outcome breakdown
OutcomeShare
Certified95.2%
Withdrawn1.6%
Denied3.2%
Certified95.2%
Withdrawn1.6%
Denied3.2%

Outcomes — Microsoft Corporation

DOL case-status mix.

Outcome breakdown: Certified 94.2%, Cert-withdrawn 5.0%, Withdrawn 0.7%, Denied 0.1%
Outcome breakdown
OutcomeShare
Certified94.2%
Cert-withdrawn5.0%
Withdrawn0.7%
Denied0.1%
Certified94.2%
Cert-withdrawn5.0%
Withdrawn0.7%
Denied0.1%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

PharmaACE LLC
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20100
FY20112
FY20120
FY20132
FY20149
FY201511
FY20164
FY20178
FY201810
FY20196
FY20205
FY202114
FY20227
FY20238
FY202418
FY202517
FY20263
Microsoft Corporation
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20104,390
FY20114,184
FY20123,943
FY20133,813
FY20143,637
FY20154,452
FY20164,888
FY20174,806
FY20185,438
FY20195,916
FY202051
FY2021110
FY2022150
FY20232,791
FY20249,492
FY20259,362
FY20262,893

Top 5 occupations — Microsoft Corporation

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.
Or browse the full sponsor index.
PharmaACE LLC vs Microsoft Corporation — H-1B Sponsor Comparison · H1B Report